Hancock Jaffe HJLI is a pre-revenue medical device company planning trials and IDE for venous valve insufficiency. They recently raise $40M in offering in mid-$7's and are now trading below that, with total market cap about $60M Added to my mid-size position here today.
HJLI PR'd their IDE application for VenoValve today:https://ir.hancockjaffe.com/press-releases/detail/95/hancock...
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |